Hepatocellular Carcinoma Organoids to Explore Tumor Microenvironment and Test Treatment Efficacy - Hepatocellular Carcinoma Liver Organoids (HELIO)

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this interventional study is to create hepatocellular carcinoma organoids from liver bioptic samples of individuals with hepatocellular carcinoma. The main questions it aims to answer are: * the feasibility of hepatocellular carcinoma organoids integrated with host gut microbiota and peripheral blood mononuclear cells * the molecular pattern of the organoid tumor microenvironment * the in vitro therapeutic response of hepatocellular carcinoma organoids

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Ability to express informed consent

• Patients ≥ 18 years of age

• Radiological diagnosis of hepatocellular carcinoma (HCC)

Locations
Other Locations
Italy
Fondazione Policlinico Agostino Gemelli IRCCS
RECRUITING
Roma
Time Frame
Start Date: 2023-06-15
Estimated Completion Date: 2025-03
Participants
Target number of participants: 10
Treatments
Experimental: Hepatocellular Carcinoma
Participants undergo to a liver biopsy, a venous blood sampling and a fecal sample collecting
Related Therapeutic Areas
Sponsors
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

This content was sourced from clinicaltrials.gov